Immunotherapy Drugs Market Segmentation by Type [Targeted Immunotherapies (Monoclonal Antibodies, Checkpoint Inhibitors, and Therapeutic Cancer Vaccines), Adoptive Cell Therapies {Tumor-Infiltrating Lymphocyte (TIL) Therapy and Natural Killer (NK) Cell Therapy}, Oncolytic Virus Therapy, Immune System Modulators {Interleukins, Interferons, and Immunomodulators (IMiDs)}, and Others]; by Therapy Area (Cancer, Infectious Diseases and Others) – Global Demand Analysis & Opportunity Outlook 2029